gallic acid has been researched along with Fibrosis in 12 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gallic acid has been reported to mitigate cardiac hypertrophy, fibrosis and arterial hypertension." | 8.12 | Syringic acid mitigates isoproterenol-induced cardiac hypertrophy and fibrosis by downregulating Ereg. ( Bai, L; Han, X; Jeong, MH; Kee, HJ, 2022) |
| "These results suggested that gallic acid may be a potential therapeutic agent for the treatment of cardiovascular diseases with hypertension and cardiac fibrosis." | 7.85 | Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. ( Cho, JY; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Piao, ZH; Ryu, Y; Sun, S, 2017) |
| "Gallic acid is a trihydroxybenzoic acid found in tea leaves and some plants." | 5.48 | Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure. ( Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Kim, HS; Liu, B; Piao, ZH; Ryu, Y; Sun, S, 2018) |
| "Gallic acid pretreatment attenuated concentric cardiac hypertrophy." | 5.43 | Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. ( Cho, JY; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Piao, ZH; Ryu, Y, 2016) |
| "Fibrosis is one of the characteristic features of chronic kidney disease (CKD)." | 5.42 | Leonurine ameliorates kidney fibrosis via suppressing TGF-β and NF-κB signaling pathway in UUO mice. ( Bo, Y; Cheng, H; Jia, Z; Li, F; Shen, W; Tan, J; Xu, C, 2015) |
| "Gallic acid has been reported to mitigate cardiac hypertrophy, fibrosis and arterial hypertension." | 4.12 | Syringic acid mitigates isoproterenol-induced cardiac hypertrophy and fibrosis by downregulating Ereg. ( Bai, L; Han, X; Jeong, MH; Kee, HJ, 2022) |
| "These results suggested that gallic acid may be a potential therapeutic agent for the treatment of cardiovascular diseases with hypertension and cardiac fibrosis." | 3.85 | Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. ( Cho, JY; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Piao, ZH; Ryu, Y; Sun, S, 2017) |
| " Hence the present study was framed to investigate the protective role of Gallic acid (GA) on AGEs induced cardiac fibrosis." | 3.80 | Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats. ( Elangovan, V; Gopi, V; Umadevi, S, 2014) |
| " Herein, we investigated the roles and the possible mechanisms of leonurine for reducing fibrotic responses in angiotensin II (Ang II)-stimulated primary neonatal rat cardiac fibroblasts and post-myocardial infarction (MI) rats." | 3.79 | Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4. ( Deng, HY; Gong, QH; Huang, GY; Liu, XH; Pan, LL; Wu, D; Xiong, QH; Zhu, YZ, 2013) |
| "Gallic acid is a trihydroxybenzoic acid found in tea leaves and some plants." | 1.48 | Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure. ( Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Kim, HS; Liu, B; Piao, ZH; Ryu, Y; Sun, S, 2018) |
| "Gallic acid pretreatment attenuated concentric cardiac hypertrophy." | 1.43 | Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. ( Cho, JY; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Lin, MQ; Piao, ZH; Ryu, Y, 2016) |
| "Fibrosis is one of the characteristic features of chronic kidney disease (CKD)." | 1.42 | Leonurine ameliorates kidney fibrosis via suppressing TGF-β and NF-κB signaling pathway in UUO mice. ( Bo, Y; Cheng, H; Jia, Z; Li, F; Shen, W; Tan, J; Xu, C, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X | 1 |
| Bai, L | 1 |
| Kee, HJ | 4 |
| Jeong, MH | 4 |
| Prasad, S | 1 |
| Marks, DH | 1 |
| Burns, LJ | 1 |
| De Souza, B | 1 |
| Flynn, EA | 1 |
| Scheinman, P | 1 |
| Silvestri, D | 1 |
| Yu, J | 1 |
| LoSicco, K | 1 |
| Senna, MM | 1 |
| Wang, R | 1 |
| Peng, L | 1 |
| Lv, D | 1 |
| Shang, F | 1 |
| Yan, J | 1 |
| Li, G | 1 |
| Li, D | 1 |
| Ouyang, J | 1 |
| Yang, J | 1 |
| Mojadami, S | 1 |
| Ahangarpour, A | 1 |
| Mard, SA | 1 |
| Khorsandi, L | 1 |
| Jin, L | 3 |
| Sun, S | 2 |
| Ryu, Y | 3 |
| Piao, ZH | 3 |
| Liu, B | 1 |
| Choi, SY | 3 |
| Kim, GR | 3 |
| Kim, HS | 1 |
| Shahzad, S | 1 |
| Mateen, S | 1 |
| Naeem, SS | 1 |
| Akhtar, K | 1 |
| Rizvi, W | 1 |
| Moin, S | 1 |
| Umadevi, S | 1 |
| Gopi, V | 1 |
| Elangovan, V | 1 |
| Cheng, H | 1 |
| Bo, Y | 1 |
| Shen, W | 1 |
| Tan, J | 1 |
| Jia, Z | 1 |
| Xu, C | 1 |
| Li, F | 1 |
| Cho, JY | 2 |
| Lin, MQ | 2 |
| Peng, CC | 1 |
| Hsieh, CL | 1 |
| Wang, HE | 1 |
| Chung, JY | 1 |
| Chen, KC | 1 |
| Peng, RY | 1 |
| Liu, XH | 1 |
| Pan, LL | 1 |
| Deng, HY | 1 |
| Xiong, QH | 1 |
| Wu, D | 1 |
| Huang, GY | 1 |
| Gong, QH | 1 |
| Zhu, YZ | 1 |
12 other studies available for gallic acid and Fibrosis
| Article | Year |
|---|---|
Syringic acid mitigates isoproterenol-induced cardiac hypertrophy and fibrosis by downregulating Ereg.
Topics: Animals; Cardiomegaly; Fibrosis; Gallic Acid; Isoproterenol; Mice; Myocardium | 2022 |
Patch testing and contact allergen avoidance in patients with lichen planopilaris and/or frontal fibrosing alopecia: A cohort study.
Topics: Acyclic Monoterpenes; Adult; Aged; Aged, 80 and over; Allergens; Alopecia; Biopsy; Cohort Studies; C | 2020 |
Leonurine Attenuates Myocardial Fibrosis Through Upregulation of miR-29a-3p in Mice Post-myocardial Infarction.
Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Disease Model | 2021 |
Diabetic nephropathy induced by methylglyoxal: gallic acid regulates kidney microRNAs and glyoxalase1-Nrf2 in male mice.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Fibrosis; Gallic Acid; Kidney; Male; Mice; Micro | 2023 |
Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure.
Topics: Animals; Aorta; Biomarkers; Cardiomegaly; Constriction, Pathologic; Fibrosis; Gallic Acid; Gene Expr | 2018 |
Syringic acid protects from isoproterenol induced cardiotoxicity in rats.
Topics: Adenosine Triphosphatases; Animals; Biomarkers; Biphenyl Compounds; Body Weight; Cardiotoxicity; Cyt | 2019 |
Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats.
Topics: Animals; Biomarkers; Body Weight; Fibrosis; Gallic Acid; Glycation End Products, Advanced; Heart; Ma | 2014 |
Leonurine ameliorates kidney fibrosis via suppressing TGF-β and NF-κB signaling pathway in UUO mice.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Epithelial-Mesenchymal Transit | 2015 |
Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity.
Topics: Animals; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fibrosis; Gallic Acid; Gene Expressi | 2016 |
Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2.
Topics: Animals; Blood Pressure; Fibrosis; Gallic Acid; Heart Ventricles; Histone Deacetylase 1; Histone Dea | 2017 |
Ferulic acid is nephrodamaging while gallic acid is renal protective in long term treatment of chronic kidney disease.
Topics: Animals; Antioxidants; Collagen; Coumaric Acids; Dietary Supplements; Disease Models, Animal; Fibros | 2012 |
Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4.
Topics: Angiotensin II; Animals; Cells, Cultured; Down-Regulation; Extracellular Signal-Regulated MAP Kinase | 2013 |